Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants

Clinical trial NCT03649464 · WITHDRAWN

Trial details

NCT number: NCT03649464
Sponsor: Oblato, Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Astrocytoma Oligodendroglioma

Start date: 2022-08-01
Primary completion: 2025-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.